Concorde Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $765K | Buy |
1,015
+115
| +13% | +$86.7K | 0.41% | 31 |
|
|
2024
Q4 | $695K | Sell |
900
-206
| -19% | -$159K | 0.36% | 46 |
|
|
2024
Q3 | $980K | Sell |
1,106
-4
| -0.4% | -$3.55K | 0.55% | 31 |
|
|
2024
Q2 | $1.01M | Buy |
1,110
+133
| +14% | +$120K | 0.62% | 27 |
|
|
2024
Q1 | $760K | Buy |
977
+21
| +2% | +$16.3K | 0.52% | 30 |
|
|
2023
Q4 | $557K | Sell |
956
-92
| -9% | -$53.6K | 0.38% | 44 |
|
|
2023
Q3 | $563K | Buy |
1,048
+35
| +3% | +$18.8K | 0.51% | 41 |
|
|
2023
Q2 | $475K | Buy |
+1,013
| New | +$475K | 0.44% | 44 |
|
|
2023
Q1 | – | Sell |
-1,009
| Closed | -$369K | – | 121 |
|
|
2022
Q4 | $369K | Sell |
1,009
-1
| -0.1% | -$366 | 0.33% | 73 |
|
|
2022
Q3 | $327K | Buy |
+1,010
| New | +$327K | 0.37% | 81 |
|
|
2022
Q2 | – | Sell |
-976
| Closed | -$279K | – | 145 |
|
|
2022
Q1 | $279K | Buy |
+976
| New | +$279K | 0.19% | 114 |
|
|
2021
Q4 | – | Sell |
-929
| Closed | -$214K | – | 186 |
|
|
2021
Q3 | $214K | Buy |
929
+45
| +5% | +$10.4K | 0.12% | 177 |
|
|
2021
Q2 | $203K | Buy |
+884
| New | +$203K | 0.11% | 187 |
|
|
2015
Q3 | – | Sell |
-2,926
| Closed | -$221K | – | 114 |
|
|
2015
Q2 | $221K | Sell |
2,926
-251
| -8% | -$19K | 0.28% | 89 |
|
|
2015
Q1 | $230K | Buy |
3,177
+160
| +5% | +$11.6K | 0.26% | 99 |
|
|
2014
Q4 | $207K | Buy |
+3,017
| New | +$207K | 0.26% | 86 |
|